Brain Tumour Research shared on LinkedIn:
“To deliver world-class research into brain tumours in the UK, scientists need reliable access to the resources, tools and expertise that enable them to pursue innovative ideas and ensure their work reflects the needs of the brain tumour community.
Since 2022, we have partnered with our sister charity brainstrust, investing in its Patient Research Involvement Movement (PRIME) to strengthen patient and public involvement in research into brain tumours.
Dr Helen Bulbeck, Co-founder and Director of Services and Policy at brainstrust, shares why she created PRIME, what the partnership with Brain Tumour Research has made possible, and where the movement goes next.”
PRIME: How research is shaped by brain tumour patients
Other articles about Brain Tumour and Brain Tumour Research on OncoDaily.